Pharmaids Pharmaceuticals Limited (BOM:524572)
India
· Delayed Price · Currency is INR 35.41
+1.41 (4.15%)
At close: Mar 10, 2026
Pharmaids Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | -107.77 | -79.68 | -75.56 | 1.45 | 0.93 | Upgrade
|
| Depreciation & Amortization | - | 24.4 | 17.25 | 0.17 | 0.08 | 0.45 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.96 | 0.2 | 0.31 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 6.23 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 8.08 | - | - | - | Upgrade
|
| Other Operating Activities | - | -42.96 | -69.47 | -23.52 | -0.04 | -0.05 | Upgrade
|
| Change in Accounts Receivable | - | -3.89 | 23.57 | 7.01 | 2.77 | -2.77 | Upgrade
|
| Change in Inventory | - | -85.93 | 7.16 | 8.88 | -5.19 | -3.69 | Upgrade
|
| Change in Accounts Payable | - | 111.41 | -12.4 | -4.23 | -1.56 | 4.91 | Upgrade
|
| Change in Other Net Operating Assets | - | -36.15 | -7.14 | 46.75 | -0.11 | 4.27 | Upgrade
|
| Operating Cash Flow | - | -139.91 | -106.2 | -40.19 | -2.59 | 4.05 | Upgrade
|
| Capital Expenditures | - | -124.81 | -228.63 | -16.73 | - | -0.02 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 2.19 | 1.47 | - | - | - | Upgrade
|
| Cash Acquisitions | - | - | -524.83 | - | - | - | Upgrade
|
| Investment in Securities | - | - | - | -32.7 | - | - | Upgrade
|
| Other Investing Activities | - | 2.39 | 2.08 | - | 4.67 | - | Upgrade
|
| Investing Cash Flow | - | -120.24 | -749.9 | -49.43 | 4.67 | -2.27 | Upgrade
|
| Long-Term Debt Issued | - | 326.96 | 15.3 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -56.67 | -24.56 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | 270.28 | -9.26 | - | - | - | Upgrade
|
| Issuance of Common Stock | - | - | 780.12 | 213.09 | - | - | Upgrade
|
| Other Financing Activities | - | -36.73 | -24.26 | - | - | - | Upgrade
|
| Financing Cash Flow | - | 233.56 | 776.6 | 213.09 | - | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -0 | - | -0 | - | - | Upgrade
|
| Net Cash Flow | - | -26.6 | -79.5 | 123.47 | 2.07 | 1.79 | Upgrade
|
| Free Cash Flow | - | -264.72 | -334.82 | -56.92 | -2.59 | 4.04 | Upgrade
|
| Free Cash Flow Margin | - | -135.66% | -218.84% | - | -6.58% | 4.72% | Upgrade
|
| Free Cash Flow Per Share | - | -7.51 | -14.74 | -4.41 | -0.25 | 0.39 | Upgrade
|
| Cash Interest Paid | - | 17.02 | 12.37 | - | - | - | Upgrade
|
| Cash Income Tax Paid | - | 0.63 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | - | -184.11 | -302.47 | -81.6 | 3.37 | 3.54 | Upgrade
|
| Unlevered Free Cash Flow | - | -171.56 | -292.83 | -81.6 | 3.37 | 3.54 | Upgrade
|
| Change in Working Capital | - | -14.55 | 11.19 | 58.41 | -4.09 | 2.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.